MARKET

YARW

YARW

YARROW BIOSCIENCE, INC.
NASDAQ
28.05
-0.89
-3.08%
After Hours: 28.59 +0.54 +1.93% 19:34 07/28 EDT
OPEN
28.94
PREV CLOSE
28.94
HIGH
28.94
LOW
26.47
VOLUME
28.31K
TURNOVER
--
52 WEEK HIGH
43.80
52 WEEK LOW
0.2157
MARKET CAP
18.71M
P/E (TTM)
-1.1188
1D
5D
1M
3M
1Y
5Y
1D
Yarrow Bioscience Completes VYNE Merger and Nasdaq Debut
TipRanks · 7h ago
Yarrow Bioscience Initiated at Buy by TD Cowen
Dow Jones · 13h ago
TD Cowen Initiates Coverage On Yarrow Bioscience with Buy Rating
Benzinga · 13h ago
Yarrow Bioscience initiated with a Buy at TD Cowen
TipRanks · 14h ago
Yarrow Bioscience And VYNE Therapeutics Compete Merger With Previously Announced Private Financings Totaling ~$200M; To Operate As Yarrow Bioscience And Trade On Nasdaq Capital Market From July 28 Under Ticker Symbol 'YARW'
Benzinga · 1d ago
Yarrow closes VYNE merger, initiates dosing in Phase 2a/2b YB-101 trial
TipRanks · 1d ago
Weekly Report: what happened at VYNE last week (0720-0724)?
Weekly Report · 1d ago
Upcoming Stock Splits This Week (July 27 to July 31) – Stay Invested
TipRanks · 2d ago
More
About YARW
VYNE Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing differentiated therapies to treat chronic inflammatory and immune-mediated conditions with high unmet need. It is developing VYN202, an oral, small molecule BD2-selective BET inhibitor. VYN202 is an oral, small molecule BD2-selective BET inhibitor that has been designed to achieve potential class-leading potency and selectivity for BD2 vs. BD1. The Company has rights to research, develop and commercialize products containing BET inhibitor compounds for the treatment of any disease, disorder or condition in humans. Utilizing its InhiBET platform and through its preclinical and clinical activities, the Company is evaluating the impact that BET inhibitor compounds have on regulating.

Webull offers Vyne Therapeutics Inc stock information, including NASDAQ: YARW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, YARW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading YARW stock methods without spending real money on the virtual paper trading platform.